Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR | Q13258 | 5/20 | 0.58 |
| ▸ | PTGIR | P43119 | 7/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL731003 | 0.93 | PTGDR (0.62) | PTGDRPTGIR | |
| SCHEMBL2116692 | 0.91 | PTGDR (0.59) | PTGDRPTGIRTBXA2R | |
| SCHEMBL2118089 | 0.87 | PTGDR (0.63) | PTGDRPTGIR | |
| SCHEMBL730943 | 0.85 | PTGIR (0.56) | PTGDRPTGIR | |
| SCHEMBL2191851 | 0.82 | PTGIR (0.64) | PTGDRPTGIR | |
| SCHEMBL2190959 | 0.80 | PTGIR (0.60) | PTGDRPTGIRTBXA2R | |
| SCHEMBL2121180 | 0.80 | PTGIR (0.58) | PTGDRPTGIRTBXA2R | |
| SCHEMBL2118980 | 0.78 | PTGDR (0.52) | PTGDRPTGIRTBXA2R | |
| SCHEMBL2117217 | 0.78 | PTGIR (0.50) | PTGDRPTGIRTBXA2R | |
| SCHEMBL730587 | 0.78 | PTGIR (0.66) | PTGDRPTGIR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2177513-B1 | PHENYLACETIC ACID COMPOUND | ONO PHARMACEUTICAL CO (JP) | 2015-07-01 | — | — | EP | disclosed |
| US-20140357630-A1 | Phenylacetic Acid Compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2014-12-04 | — | — | US | disclosed |
| US-8809524-B2 | Phenylacetic acid compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20130225808-A1 | PHENYLACETIC ACID COMPOUND | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
| US-8476266-B2 | Phenylacetic acid compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-20130028887-A1 | PHENYLACETIC ACID COMPOUND | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-8318729-B2 | Phenylacetic acid compound | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20120094990-A1 | PHENYLACETIC ACID COMPOUND | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| EP-2177513-A1 | PHENYLACETIC ACID COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2010-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225808-A1 | PHENYLACETIC ACID COMPOUND | PC, PAH, PDHA2 | PTGDR 1630/4885PTGIR 3123/4885TBXA2R 2310/4885 |
| US-20120094990-A1 | PHENYLACETIC ACID COMPOUND | PC, PAH, PDHA2 | PTGDR 1630/4885PTGIR 3123/4885TBXA2R 2310/4885 |
| US-20130028887-A1 | PHENYLACETIC ACID COMPOUND | PC, PAH, PDHA2 | PTGDR 1630/4885PTGIR 3123/4885TBXA2R 2310/4885 |
| US-20140357630-A1 | Phenylacetic Acid Compound | PC, PAH, PDHA2 | PTGDR 1630/4885PTGIR 3123/4885TBXA2R 2310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.